Profound Medical Income Statement (2018-2026) | PROF

Income Statement Dec2018 Jan2019 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 1.44M1.95M2.54M4.18M2.62M2.21M5.29M5.98M5.34M
Cost of Revenue (Quarter) 0.57M0.81M1.04M1.21M0.77M0.59M1.36M1.99M1.50M
Gross Profit (Quarter) 0.87M1.42M1.79M2.96M1.85M1.62M3.93M3.99M3.83M
Operating items
Research & Development (Quarter) 3.94M4.21M4.17M4.65M4.81M6.10M5.42M4.27M5.26M
Selling, General & Administrative (Quarter) 4.80M5.06M6.62M6.66M8.21M9.33M7.43M7.09M6.59M
Operating Expenses (Quarter) 8.74M9.26M10.79M11.31M13.02M15.42M12.84M11.36M11.85M
Operating Income (Quarter) -7.88M-7.84M-9.00M-8.35M-11.17M-13.81M-8.91M27.54M-8.02M
EBIT (Quarter) -7.88M-7.84M-9.00M-8.35M-11.17M-13.81M-8.91M27.54M-8.02M
Non-operating items
Interest & Investment Income (Quarter) 0.46M0.42M0.22M0.33M0.45M0.34M0.12M0.16M0.38M
Other Non Operating Income (Quarter) 0.87M0.52M-0.41M-0.77M0.04M-2.17M0.94M2.29M0.62M
Non Operating Income (Quarter) 1.33M0.94M-0.19M-2.23M0.48M-1.82M1.06M0.30M0.99M
Net income details
EBT (Quarter) -6.54M-6.90M-9.19M23.10M-10.68M-15.63M-7.86M-8.15M-7.03M
Tax Provisions (Quarter) 0.04M0.02M0.18M-0.09M0.04M0.08M0.12M0.01M0.03M
Profit After Tax (Quarter) -6.58M-6.92M-9.37M-4.95M-10.72M-15.70M-7.98M-8.18M-7.05M
Income from Continuing Operations (Quarter) -6.58M-6.92M-9.37M23.19M-10.72M-15.71M-7.98M-8.16M-7.05M
Consolidated Net Income (Quarter) -6.58M-6.92M-9.37M23.19M-10.72M-15.71M-7.98M-8.16M-7.05M
Income towards Parent Company (Quarter) -6.58M-6.92M-9.37M23.19M-10.72M-15.71M-7.98M-8.16M-7.05M
Net Income towards Common Stockholders (Quarter) -6.58M-6.92M-9.37M50.69M10.72M-15.70M-7.98M76.97M7.05M
Additional items
EPS (Basic) (Quarter) 0.270.280.380.180.360.520.260.270.19
EPS (Weighted Average and Diluted) (Quarter) 0.270.280.380.180.360.520.260.270.19
Shares Outstanding (Weighted Average) (Quarter) 8.19M88.65M8.98M211.53M20.78M0.77M21.18M24.30M24.44M24.53M24.77M30.04M30.06M30.12M30.23M36.30M
Shares Outstanding (Diluted Average) (Quarter) 21.18M24.30M24.37M24.43M24.77M30.04M30.06M30.10M30.23M36.30M
EBITDA (Quarter) -7.55M-7.39M-8.78M-6.92M-10.62M-12.98M-8.79M-7.90M-8.06M
Tax Rate (Quarter) -0.61%-0.28%-1.93%-0.40%-0.38%-0.50%-1.54%-0.15%-0.38%